Atlas Trials

Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis

Clinical trial NCT01159769 · COMPLETED

Trial details

NCT number
NCT01159769
Sponsor
Alcon Research
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Allergic Conjunctivitis
Start date
2010-06-01
Primary completion
2010-08-01
Enrollment
215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.